| 401 | SEPNSepterna, Inc. |
$46M |
-106.4% |
2025 |
| 402 | TLSITriSalus Life Sciences, Inc. |
$45.2M |
-86.9% |
2025 |
| 403 | FENCFennec Pharmaceuticals Inc. |
$44.6M |
-21.8% |
2025 |
| 404 | AQSTAquestive Therapeutics, Inc. |
$44.5M |
-188.1% |
2025 |
| 405 | CPIXCumberland Pharmaceuticals Inc |
$44.5M |
-6.4% |
2025 |
| 406 | SNWVSANUWAVE Health, Inc. |
$44.1M |
26.8% |
2025 |
| 407 | INBPIntegrated Biopharma Inc |
$43.9M |
-6.5% |
2026 |
| 408 | XLOXilio Therapeutics, Inc. |
$43.8M |
-80.1% |
2025 |
| 409 | WVEWave Life Sciences Ltd. |
$42.7M |
-478.3% |
2025 |
| 410 | SSIISS Innovations International, Inc. |
$42.5M |
-28.5% |
2025 |
| 411 | CHRSCoherus Oncology, Inc. |
$42.2M |
398.4% |
2025 |
| 412 | BFRIBiofrontera Inc. |
$41.7M |
-25.3% |
2025 |
| 413 | KRMDKORU Medical Systems, Inc. |
$41.1M |
-6.4% |
2025 |
| 414 | BWAYBrainsway Ltd. |
$41M |
7.1% |
2024 |
| 415 | MYOMyomo, Inc. |
$40.9M |
-38.1% |
2025 |
| 416 | EDITEditas Medicine, Inc. |
$40.5M |
-395.0% |
2025 |
| 417 | TKNOAlpha Teknova, Inc. |
$40.5M |
-42.6% |
2025 |
| 418 | VYGRVoyager Therapeutics, Inc. |
$40.4M |
-296.5% |
2025 |
| 419 | SGMOQSangamo Therapeutics, Inc |
$39.6M |
-310.8% |
2025 |
| 420 | KYMRKymera Therapeutics, Inc. |
$39.2M |
-794.0% |
2025 |
| 421 | IDXGInterpace Biosciences, Inc. |
$38.7M |
63.5% |
2025 |
| 422 | UTMDUtah Medical Products Inc |
$38.5M |
29.3% |
2025 |
| 423 | RVPRetractable Technologies Inc |
$38.3M |
-32.8% |
2025 |
| 424 | BGMBGM Group Ltd. |
$37.9M |
-52.6% |
2025 |
| 425 | CTSOCytosorbents Corp |
$37.1M |
-22.1% |
2025 |
| 426 | CLPTClearPoint Neuro, Inc. |
$37M |
-69.1% |
2025 |
| 427 | LIFDLftd Partners Inc. |
$36.9M |
-67.3% |
2025 |
| 428 | SBFMSunshine Biopharma Inc. |
$36.3M |
-16.5% |
2025 |
| 429 | CCCCC4 Therapeutics, Inc. |
$35.9M |
-292.1% |
2025 |
| 430 | ETSTEarth Science Tech, Inc. |
$35.7M |
10.2% |
2026 |
| 431 | ZSTKZeroStack Corp. |
$35.7M |
-335.6% |
2025 |
| 432 | VRCAVerrica Pharmaceuticals Inc. |
$35.6M |
-50.3% |
2025 |
| 433 | SENSSenseonics Holdings, Inc. |
$35.3M |
-196.0% |
2025 |
| 434 | XFORX4 Pharmaceuticals, Inc |
$35.1M |
-225.6% |
2025 |
| 435 | LEEEFLeef Brands Inc. |
$34.8M |
-50.7% |
2025 |
| 436 | BHSTBioharvest Sciences Inc. |
$34.5M |
-32.3% |
2025 |
| 437 | DTILPrecision Biosciences Inc |
$34.3M |
-133.4% |
2025 |
| 438 | OBIOOrchestra BioMed Holdings, Inc. |
$33.5M |
-157.4% |
2025 |
| 439 | SONXSonendo, Inc. |
$33.2M |
-84.4% |
2024 |
| 440 | MXCTMaxcyte, Inc. |
$33M |
-135.1% |
2025 |
| 441 | CWLXFC21 Investments Inc. |
$32.6M |
-9.9% |
2026 |
| 442 | STXSStereotaxis, Inc. |
$32.4M |
-66.8% |
2025 |
| 443 | ECORelectroCore, Inc. |
$32M |
-43.6% |
2025 |
| 444 | ZOMDFZomedica Corp. |
$32M |
-255.6% |
2025 |
| 445 | PREMPremier Air Charter Holdings Inc. |
$31.9M |
-12.1% |
2025 |
| 446 | CCELCryo Cell International Inc |
$31.6M |
-7.7% |
2025 |
| 447 | POCIPrecision Optics Corporation, Inc. |
$31.5M |
-11.5% |
2026 |
| 448 | VSTMVerastem, Inc. |
$30.9M |
-677.6% |
2025 |
| 449 | FHTXFoghorn Therapeutics Inc. |
$30.9M |
-240.3% |
2025 |
| 450 | SNYRSynergy CHC Corp. |
$30.4M |
-40.6% |
2025 |